Adam Weinfeld, MD
Plastic and Reconstructive Surgery · Austin, TXNPI 1346363280
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,356 of the $19,606 with a category attached, or 68.1%. Elutia, Inc. accounts for 63.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $6,603 and has fallen 90.4% since, to $634 in 2025. Among plastic and reconstructive surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $251.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elutia, Inc.$13K
- Motiva USA, LLC$3K
- AbbVie$2K
- Axogen$691
- TELA Bio, Inc.$377
- Sientra, Inc.$275
- plus $1K from 8 others
Across 7 payments — averaging $3119.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Elutia, Inc.$22K
What the payments were for
- Consulting fees$13,35668%
- Travel & lodging$1,2156%
- Food & beverage$5,03526%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elutia, Inc. | 15 | $12,535 |
| Motiva USA, LLC | 9 | $2,591 |
| AbbVie(2 entities) | 27 | $2,053 |
| Axogen | 7 | $691 |
| TELA Bio, Inc. | 3 | $377 |
| Sientra, Inc. | 3 | $275 |
| Merz North America, Inc. | 4 | $232 |
| Mentor Worldwide LLC | 3 | $212 |
| Galderma Laboratories, L.p. | 2 | $200 |
| Davol Inc. | 1 | $137 |
| Pacira Pharmaceuticals Incorporated | 1 | $111 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $90 |
| Integra Lifesciences Corporation | 1 | $80 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SimpliDerm ,Integuply$6,431
- SimpliDerm$5,316
- Motiva Implant Matrix$2,396
- NATRELLE SALINE-FILLED BREAST IMPLANTS$1,178
- AVANCE NERVE GRAFT$402
- OviTex 2S$294
- ALLODERM$289
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$175
- AxoGuard Nerve Connector$150
- AxoGuard Nerve Protector$150
- AXOGUARD HA+ NERVE PROTECTOR$150
- AxoGuard Nerve Cap$150
- NATRELLE$140
- Phasix Mesh$137
- MemoryGel Breast Implants$125
- EXPAREL$111
How this compares
$19,606 in reported general payments places this provider in the 90th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 35 | $90 |
| Ondansetron Hcl | 11 | $53 |
| Gabapentin | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Austin
- Alina SholarAustin$110K
- Jeffery HallAustin$42K
- Rocco PiazzaAustin$39K
- Richard HopperAustin$27K
- Christine FisherAustin$23K
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.